NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GALVUMET® Vildagliptin/Metformin hydrochloride Consumer Medicine Information What
Continue reading »
Home »
FDA approves first noninjection glucagon therapy
(HealthDay)—The U.S. Food and Drug Administration has approved the first noninjection glucagon therapy for emergency treatment of severe hypoglycemia, the
Continue reading »